Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

09/24/11 Noscapine inhibits tumor growth in TMZ-resistant gliomas.        

09/24/11 Isolation of a new cell population in the glioblastoma microenvironment.        

09/21/11 Emerging Technologies In Brain Cancer Therapy        

09/20/11 Free Art Workshop - NJ        

09/19/11 Breaching the Blood-Brain Barrier        

09/17/11 BRAINSTORM: A Dialogue and Education Series NONMALIGNANT AND LOW-GRADE BRAIN TUMORS: SURVIVING AND THRIVING MONDAY, SEPTEMBER 19, 2011 (NL)        

09/17/11 Long Island 5k Run Oct 1        

09/17/11 Clinical Trial Tests Investigational New Drug for Malignant Brain Tumors        

09/16/11 Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bev acizumab-induced Invasion in U87 Glioma.        

09/16/11 Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms        

09/16/11 Blocking Cholesterol in Brain Cancer Cells Offer a New Strategy to Fight Deadly Glioblastomas        

09/13/11 Sulfasalazine May Curtail Glioma-Related Seizures        

09/13/11 Pharma Strategy Blog: Roche files vismodegib for basal cell carcinoma with FDA [Editor's note: although not for brain tumors - this may open the door for using it for some types of brain tumors]        

09/13/11 NIH-funded research points to potential therapy for tumor-associated epilepsy        

09/12/11 FDA Clears IsoRay's GliaSite(R) Treatment for Brain Cancer        

09/12/11 ImmunoCellular Therapeutics Announces 55% Overall Survival at Three years from Phase I Study in Glioblastoma

38% of patients disease free at 3 years

       

09/10/11 Human Cytomegaloviru s US28 Found in Glioblastoma Promotes an Invasive and Angiogenic Phenotype.        

09/09/11 Flo's 2nd Annual Chili Cook-Off - NJ        

09/09/11 IBTA E NEWS AUGUST-SEPTEMBER 2011        

---

Displaying Stories 2790 to 2809 of 7806
Previous 20           Next 20